Procoralan, a new selective If current inhibitor

European Heart Journal, Supplement

Volumn 5, Issue G, 2003, Pages

  Vilaine, J P ^a   Thollon, C ^a   Villeneuve, N ^a   Peglion, J L ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Heart rate; If current; Ivabradine; Procoralan; Sinus node

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYCLOBUTANE DERIVATIVE; INDAN DERIVATIVE; IVABRADINE; PROPRANOLOL; S 15544; UNCLASSIFIED DRUG;

ATRIOVENTRICULAR CONDUCTION; CLINICAL TRIAL; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; ELECTRIC CURRENT; EXERCISE; FUNNY CURRENT; HEART DEPOLARIZATION; HEART FAILURE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART RATE; HEART REPOLARIZATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; ISCHEMIC HEART DISEASE; MUSCLE ACTION POTENTIAL; NONHUMAN; PACEMAKER; PRIORITY JOURNAL; REST; REVIEW; SINUS NODE;

EID: 0141917488     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(03)90005-8     Document Type: Review

References (38)

1. Matsuzaki M, Patritti J, Tajimi T, et al. Effects of β-blockade on regional myocardial flow and function during exercise. Am J Physiol 1984;56:H52-60.
2. Guth BD, Heusch G, Steitelberger R, Ross J Jr. Mechanism of beneficial effect of β-adrenergic blockade on exercise-induced myocardial ischemia in conscious dogs. Circ Res 1987;60:738-46.
3. Guth BD, Indolfi C, Heusch G, et al. Mechanism of benefit in the ischemic myocardium due to heart rate reduction. Basic Res Cardiol 1990;85:157-66.
4. Guth BD, Heusch G, Steitelberger R, Ross J Jr. Elimination of exercise-induced regional myocardial dysfunction by a bradycardic agent in dogs with chronic coronary artery stenosis. Circulation 1987;75:661-9.
5. Indolfi C, Guth BD, Miura T, et al. Mechanism of improved ischemic regional dysfunction by bradycardia. Studies on UL-FS 49 in swine. Circulation 1989;80:1365-9.
6. Dyer AR, Persky V, Stamler J, et al. Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 1980;112:736-49.
7. Friedman GD, Klatsky AL, Siegelaub AB. Predictors of sudden cardiac death. Circulation 1975;52:164-9.
8. Hjalmarson A, Gilpin EA, Kjekshus JK, et al. Influence of heart rate on mortality after acute myocardial infarction. Am J Cardiol 1990;65:547-53.
9. Gillum RF, Makuc DM, Feldman JJ. Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 1991;121:172-7.
10. Kannel WB, Kannel C, Paffengarger RS Jr, Cupples LA. Heart rate and cardiovascular mortality: the Framingham Study. Am Heart J 1987;113:1489-94.
11. Wilhelmsen L, Berglund G, Elmfeldt D, et al. The multifactor primary prevention trial in Goteborg, Sweden. Eur Heart J 1986;7:279-88.
12. Gundersen T, Grottum P, Pedersen T, Kjekshus JK, for the Norwegian Multicenter Group. Effect of timolol on mortality and reinfarction after acute myocardial infarction: prognostic importance of heart rate at rest. Am J Cardiol 1986;58:20-5.
13. Kjekshus J. Importance of heart rate in determining beta-blocker efficacy in acute and long-term myocardial infarction intervention trials. Am J Cardiol 1986;57:43F-9F.
14. Frishman WH, Furberg CD, Friedewald WT. β-adrenergic blockade in survivors of acute myocardial infarction. N Engl J Med 1984;310:830-7.
15. The Multicenter Diltiazem Postinfarction Trial Research Group. Effect of diltiazem on mortality and reinfarction after myocardial infarction. N Engl J Med 1988;319:85-92.
16. The Danish Study Group on Verapamil in Myocardial Infarction. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II - DAVIT II). Am J Cardiol 1990;66:779-85.
17. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55.
18. CIBIS Investigators and Committees. A randomised trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765-73.
19. Nul DR, Doval HC, Grancelli HO, et al. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. J Am Coll Cardiol 1997;29:1199-205.
20. Peglion JL, Vian J, Thollon C, et al. S 16257, a novel sinoatrial node modulator: potent bradycardic activity with improved specificity [abstract]. Can J Physiol Pharmacol 1994;72(Suppl 1):95.
21. Thollon C, Cambarrat C, Vian J, et al. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol 1994;112:37-42.
22. Thollon C, Bibouard JP, Cambarrat C, et al. Stereospecific in vitro and in vivo effects of the new sinus node inhibitor (+)-S 16257. Eur J Pharmacol 1997;339:43-51.
23. Carmeliet E. Electrophysiologic and voltage clamp analysis of the effects of Sotalol on isolated cardiac muscle and Purkinje fibers. J Pharmacol Exp Ther 1985;232:817-25.
24. Abrahamsson C, Duker G, Lundberg C, Carlsson L. Electrophysiological and inotropic effects of H 234/09 (almokalant) in vitro: a comparison with two other novel Ik blocking drugs, UK-68,768 (Dofetilide) and E-4031. Cardiovasc Res 1993;27:861-7.
25. Irisawa H, Brown HF, Giles W. Cardiac pacemaking in the sinoatrial node. Physiol Rev 1993;73:197-227.
26. Brown HF, DiFrancesco D, Noble SJ. How does adrenaline accelerate the heart? Nature 1979;280:235-6.
27. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Ann Rev Physiol 1993;55:451-67.
28. DiFrancesco D. The onset and autonomic regulation of cardiac pacemaker activity: relevance of the current. Cardiovasc Res 1995;29:449-56.
29. f) plays an important role in regulating SA node pacemaker activity. Cardiovasc Res 1995;30:307-8.
30. Bois P, Bescond J, Renaudon B, Lenfant J. Mode of action of bradycardic agent, S 16257, on ionic currents of rabbit sinoatrial node cells. Br J Pharmacol 1996;118:1051-7.
31. f) by cAMP in the rabbit sino-atrial node. J Physiol 1994;474:473-82.
32. f) in cells isolated from the rabbit sino-atrial node. J Physiol (Lond) 1986; 377:61-88.
33. f. Pflügers Arch 1987;410:139-42.
34. Simon L, Ghaleh B, Puybasset L, et al. Coronary and haemodynamic effects of S 16257, a new bradycardic agent, in resting and exercising conscious dogs. J Pharmacol Exp Ther 1995;275:659-66.
35. Berdeaux A, Drieu La Rochelle C, Richard V, Giudicelli JF. Opposed responses of large and small coronary arteries to propranolol during exercise in dogs. Am J Physiol 1991;261:H265-70.
36. Drieu La Rochelle C, Giudicelli JF, Berdeaux A. Differential effects of celiprolol and atenolol on large epicardial coronary arteries in conscious dogs at rest and during exercise. J Cardiovasc Pharmacol 1993;22:15-21.
37. 2-Adrenergic control of large and small coronary arteries during exercise in conscious dogs under β-blockade. Fund Clin Pharmacol 1993;7:520-7.
38. Vilaine JP, Bidouard JP, Lesage L, et al. Anti-ischemic effects of ivabradine, a selective heart rate reducing agent, in exercise-induced myocardial ischemia in pigs. J Cardiovasc Pharmacol (in press).